• Australian (ASX) Stock Market Forum

Hello and welcome to Aussie Stock Forums!

To gain full access you must register. Registration is free and takes only a few seconds to complete.

Already a member? Log in here.

IXC - Invex Therapeutics

Discussion in 'Stocks I-P' started by System, Jun 11, 2019.

  1. System

    System Administrator

    Likes Received:
    Jun 27, 2010
    Invex Therapeutics is a biopharmaceutical company focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure, such as Idiopathic Intracranial Hypertension (IIH), acute stroke and traumatic brain injury.

    The Company intends to achieve this through the research, development and potential commercialisation of more than 10 years of scientific discovery and technology development by Dr Alexandra J Sinclair and her group at The University of Birmingham, UK.

    It is anticipated that IXC will list on the ASX during July 2019.

    michael901446 likes this.

Share This Page